Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001209191-21-029073

Chief Financial Officer acquired 28,718 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Finley John David · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-04-27 Grant or award : show line 1 in the form +2,396 2,396 D
2021-04-27 Grant or award : show line 2 in the form +26,322 26,322 I

Table II: Derivative

19 lines
Date Transaction Shares Owned after D/I
2021-04-27 Grant or award : show line 3 in the form Stock Option (Right to Buy) +10,418 10,418 D
2021-04-27 Grant or award : show line 4 in the form Stock Option (Right to Buy) +9,516 9,516 D
2021-04-27 Grant or award : show line 5 in the form Stock Option (Right to Buy) +52,068 52,068 D
2021-04-27 Grant or award : show line 6 in the form Stock Option (Right to Buy) +14,708 14,708 D
2021-04-27 Grant or award : show line 7 in the form Stock Option (Right to Buy) +5,662 5,662 D
2021-04-27 Grant or award : show line 8 in the form Stock Option (Right to Buy) +19,033 19,033 D
2021-04-27 Grant or award : show line 9 in the form Stock Option (Right to Buy) +9,702 9,702 D
2021-04-27 Grant or award : show line 10 in the form Stock Option (Right to Buy) +7,952 7,952 D
Loading xslF345X03/doc4.xml…